Wolverine Asset Management LLC Buys New Stake in NewAmsterdam Pharma (NASDAQ:NAMSW)

Wolverine Asset Management LLC bought a new stake in shares of NewAmsterdam Pharma (NASDAQ:NAMSW) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 12,693 shares of the company’s stock, valued at approximately $181,000.

NewAmsterdam Pharma Price Performance

NASDAQ:NAMSW opened at $8.00 on Tuesday. NewAmsterdam Pharma has a 52 week low of $5.52 and a 52 week high of $16.75. The firm has a 50 day moving average of $11.88 and a 200 day moving average of $9.85.

NewAmsterdam Pharma Company Profile

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases.